This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Small-Cap Winners & Losers

McCormick & Schmick's (MSSR) was among the biggest small-cap losers Tuesday in a mostly down day for the sector.

Shares plunged 23.1% after the Portland, Ore., seafood-restaurant chain sliced 5 cents off the low end of its prior third-quarter income guidance to about 16 cents a share. Same-store sales are now pegged to be flat vs. the prior forecast for a gain of between 1.5% and 2.5%, and the total-sales estimate was lowered by $2 million from the earlier low end to roughly $88 million.

Thomson Financial's estimates call for 22 cents a share, less extraordinary items, on total revenue of $90.6 million. McCormick shares lost $5.78 to $19.28.

Another small-cap name, Panacos Pharmaceuticals (PANC), slid 21% on news chief financial officer Peyton Marshall had resigned. VP Robert Pelletier will replace him in the interim. Shares of the Watertown, Mass., biotech company were off 53 cents at $1.99.

And Standard Pacific (SPF) sank 10.6% after UBS began coverage on the Irvine, Calif., homebuilder with a sell rating. The move comes a day after the company priced a $100 million convertible-senior-bond offering and eliminated its 4-cent quarterly dividend.

Standard Pacific shares shed 75 cents to $6.30. That helped pressure the Russell 2000, which also harbors McCormick, as well as the S&P SmallCap 600. Both trackers were lately losing around 0.4%.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
PANC $0.00 0.00%
STP $0.53 0.00%
ZVUE $0.00 0.00%
APPY $0.33 0.03%
SPF $40.00 403.14%


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs